NCT02970669 - Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

December 16, 2016

Primary Completion Date

March 19, 2018

Study Completion Date

March 19, 2018

Conditions

Heart Failure, Reduced Ejection Fraction

Interventions

DRUG

sacubitril/valsartan (LCZ696)

sacubitril/valsartan tablet taken orally.

DRUG

enalapril

Enalapril tablet taken orally.

DRUG

matching placebo sacubitril/valsartan (LCZ696)

matching placebo sacubitril/valsartan tablet taken orally

DRUG

matching placebo enalapril

matching placebo enalapril tablet taken orally

Trial Locations (23)

21093

Novartis Investigative Site, Lutherville

23114

Novartis Investigative Site, Midlothian

29203

Novartis Investigative Site, Columbia

29615

Novartis Investigative Site, Greenville

29720

Novartis Investigative Site, Lancaster

32127

Novartis Investigative Site, Port Orange

32174

Novartis Investigative Site, Ormond Beach

33126

Novartis Investigative Site, Doral

34452

Novartis Investigative Site, Inverness

35967

Novartis Investigative Site, Fort Payne

75013

Novartis Investigative Site, McKinney

75092

Novartis Investigative Site, Sherman

77375

Novartis Investigative Site, Tomball

78130

Novartis Investigative Site, New Braunfels

78229

Novartis Investigative Site, San Antonio

78666

Novartis Investigative Site, San Marcos

90211

Novartis Investigative Site, Beverly Hills

91307

Novartis Investigative Site, West Hills

95204

Novartis Investigative Site, Stockton

98405

Novartis Investigative Site, Tacoma

08816

Novartis Investigative Site, East Brunswick

07450

Novartis Investigative Site, Ridgewood

75002-3688

Novartis Investigative Site, Allen